A pilot study was performed for the development of a method to screen compound libraries using an electrospray mass spectrometer interfaced with liquid chromatography (LC). The mixture of compounds was obtained by combining low-molecular weight inhibitors of carboxypeptidase A (CPA), a representative zinc-containing proteolytic enzyme. After the incubation of the mixture with CPA, the enzyme-bound compounds were separated by size exclusion chromatography (SEC) from unbound compounds. The separation of compounds was affected by LC. Three compounds were identified, which represent the tight binding inhibitors of the library. These compounds were quantitated using an automatic switching valve to avoid the interference of buffer salts with the detection of analytes. The quantitated amounts of the compounds were found to be in good accordance with the K i values. (Journal of Biomolecular Screening 2005:30-35) 
INTRODUCTION
C OMBINATORIAL CHEMISTRY AND HIGH-THROUGHPUT SCREENING (HTS) have emerged as new paradigms in pharmaceutical research: combinatorial chemistry provides a vast number of new chemical entities over a short time scale, and HTS screens the chemical library for biologically active compounds quite efficiently and rapidly. Mass spectrometry (MS) has been used extensively for analyzing proteins and protein-compound complexes, 1,2 but the application of mass spectrometry to the screening of protein-bound compounds requires coupling of MS with a suitable method that separates the bound from unbound compounds. 3, 4 We have recently reported a mass spectrometrybased qualitative screening method that uses centrifugal ultrafiltration for the separation of protein-bound compounds from unbound compounds. 5 In this article, we describe another qualitative approach to screen compound libraries using a combination of size exclusion chromatography (SEC) and mass spectrometry, which also can be used quantitatively.
Most binding assays are commonly carried out under conditions in which salts may be present at concentrations high enough to interfere with MS detection. [6] [7] [8] Consequently, the removal of salts from the sample before MS analysis is desirable. The available methods, such as desalting using solid-phase extraction (SPE), liquid-liquid extraction (LLE), or ion-exchange chromatography, are time-consuming and thus not suitable for highthroughput analyses. Online SPE or MS microchips have also been used for rapid sample cleanup before analyses. 9, 10 We solved this problem by employing an automatic switching valve during liquid chromatography-mass spectrometry (LC-MS) analyses, which diverted the flow from the high-performance liquid chromatography (HPLC) column to waste in order to avoid the interference of early eluting salts on the analyte signals.
Carboxypeptidase A (CPA), a zinc-containing proteolytic enzyme, catalyzes the removal of the carboxy-terminal amino acid residue possessing a hydrophobic side chain from the protein substrate. 11 CPA has been used as a model target enzyme for developing strategies for the design of new inhibitors of other zinc proteases of medicinal interest, such as angiotensin-converting enzyme and matrix metalloproteases. [12] [13] [14] CPA was selected as a model enzyme for this pilot study, and low-molecular weight competitive inhibitors 15, 16 for the enzyme were combined to obtain the CPA inhibitor mix. These inhibitors bind to the active site of CPA noncovalently. 17 In the present method, the LC-MS is equipped with an electrospray ionization (ESI) system, and compounds binding to the protein were identified and quantitated. 15, 16 were calculated from the semireciprocal plot of the initial velocity versus concentration of the inhibitors. 22 b. Tandem mass spectrometry (MS/MS) fragments of the compounds obtained using collision energy from 0 to 60 V. The main fragment, with the highest intensity shown in bold, was used for the multiple-reaction monitoring (MRM) mode in qualitative analyses. c. Retention times of the components of the CPA inhibitor mix obtained from the analysis of the standard sample using optimized liquid chromatography (LC) separation (method 1), as shown in Figure 3 . d. Collision energy (CE) used for MS/MS mode. e. Chong and Auld. 23 f. Compound 8 was used as a negative control.
CPA inhibitor mix
The CPA inhibitor mix was obtained by mixing compounds 1 through 8 in equimolar amounts. Each compound of the CPA inhibitor mix was prepared in 0.05 M Tris/0.5 M NaCl buffer at an initial stock concentration of 1 mM. The pH was adjusted to 7.5. Subsequently, equal volumes of the different stock solutions were mixed, and this mixture was used as the CPA inhibitor mix. The cysteine derivatives were prepared fresh to avoid the oxidation of the free mercapto group in water, which occurs within 1 day.
Incubation of CPA with the CPA inhibitor mix
The CPA stock solution was prepared by dissolving the enzyme in Tris/NaCl buffer (pH 7.5). CPA (16.6 µM) was incubated with the CPA inhibitor mix (individual compound concentration: 125 µM) for 30 min at room temperature (RT). The resulting incubation mixture was then subjected to gel filtration for the separation of binding compounds from nonbinding compounds.
Gel filtration
Prior to gel filtration, the columns were equilibrated using 10 mL of Tris/NaCl buffer (7-8 min). The samples were then loaded (350 µL), followed by the addition of 150 µL of Tris/NaCl buffer to make up the total sample volume of 500 µL. Subsequently, the columns were eluted using 1 mL of Tris/NaCl buffer (2 min). To optimize the filtration, the eluate (1 mL) was first collected in 20 fractions of 50 µL each. Each fraction was separately analyzed using LC-MS/MS. The analyses showed the absence of unbound compounds in fractions 1 to 15. A total of 750 µL of the eluate was collected for the succeeding experiments. The incubation mixture without enzyme was used as a blank for the control of the filtration procedure. An additional control was employed using Tris/NaCl buffer to avoid incorporation of any sort of impurities, which might originate from the gel filtration columns. Subsequently, the standards and the samples were subjected to LC-MS analyses. The different steps of the screening procedure are outlined in Figure 2 .
LC-MS/MS analyses
The analyses were performed using a TSQ Quantum mass spectrometer equipped with an ESI source and a triple quadrupole mass detector (ThermoFinnigan, San Jose, CA). MS detection of every compound was optimized using the following parameters: spray voltage (3.7 kV), nitrogen sheath gas pressure (3.2 × 10 5 Pa), auxiliary gas pressure (1.3 × 10 5 Pa), capillary temperature (400°C ), and capillary voltage (35 V). The MS/MS experiments were also carried out to confirm the characteristic fragmentation patterns of the compounds of the CPA inhibitor mix (data not shown). The collision energy was optimized in each case. The main fragments obtained from the MS/MS fingerprinting of each compound are presented in Figure 1 .
Mass spectra were recorded in the multiple-reaction monitoring (MRM) mode for qualitative analyses, whereas the quantitative runs were made by applying single-ion monitoring (SIM) mode. The gradient was shifted by 2 min, and the switching valve was applied at 2 positions, 0.5 min before the retention time of the first compound and 0.5 min after the retention time of the second compound. The rest of the eluate was directed to the waste as described by Wang et al. 18 The samples were analyzed in the positive ion mode. Xcalibur software was used for data acquisition and plotting.
All samples were injected by the autosampler (Surveyor ® , ThermoFinnigan) after optimization of MS conditions. RP C18 HD (Macherey-Nagel GmbH, Dueren, Germany) was used as the 0 stationary phase. The solvent system comprised 10 mM ammonium acetate buffer in water containing 0.1% TFA (A) and 0.1% TFA in acetonitrile (B). The flow rate of the mobile phase was set to 250 µL. The following elution profiles were used for qualitative (method 1) and quantitative (method 2) analyses:
Method 1: From 0 to 7 min, the percentage of B in the mixture of 90% of A and 10% of B was increased to 80%, followed by a sharp decrease in the percentage of B from 80% to 10% by 1 min (7-8 min). From 8 to 10 min, an isocratic run of 90% of A and 10% of B was used. Method 2: An isocratic run of 90% of A and 10% of B for 2 min was used, followed by the aforementioned gradient.
Sample preparation for LC-MS analyses
Prior to LC-MS analyses, all the samples were diluted 1:10 with a mixture of water (90%), acetonitrile (10%), and TFA (0.1%). The acidification of the enzyme inhibitor complexes before analyses resulted in the disruption of the complexes, as described by Mathur et al. 5
Determination of protein recovery
The recovery of CPA from gel filtration columns was determined using the BCA-200 (bicinchoninic acid) protein assay kit. Gel filtration of CPA was performed in the same way as mentioned before. The calibration curve was prepared using different concentrations of bovine serum albumin (BSA), followed by the determination of the concentration of CPA in the samples photometrically (572 nm) using a multilabel plate reader (Wallac1420 Victor2, PerkinElmer Life Sciences).
RESULTS

Analysis of the CPA inhibitor mix
The LC separation of the CPA inhibitor mix was first optimized to achieve an optimal separation of the different compounds (Fig.   3 ). The MRM mode exclusively provides a selective detection of the analyte on the basis of its fragment ion, which can be monitored and quantitated amid a complicated matrix. The detection of Tris (m/z: 122, RT: 2.46 min), a buffer component, in the MRM window of 1 was unavoidable because of the same molecular masses and fragment ions.
Incubation mixture after gel filtration
The sample obtained after gel filtration (750 µL) was injected directly to the LC-MS system. The chromatogram depicted in Figure 4 illustrates the presence of 3 compounds-namely, 3, 4, and 5-which were bound to the enzyme. Considering the K i values of the components of the CPA inhibitor mix, it is likely that these compounds represent the tight binding inhibitors in the mixture. No compound could be detected in the control experiment performed without enzyme. CPA could also be observed in a separate run by applying the same gradient in FullScan mode (data not shown).
Quantitation of binding compounds
To determine the amounts of tight binding inhibitors bound to CPA, we quantitated them using the calibration curves, as shown in der of magnitude from 0.05 to 0.5 µM, and the linearity factor was 0.994 for both compounds. The quantitated amounts of 4 and 5 were 18 pmol and 347 pmol, respectively ( Table 1 ). The amount of protein in the sample was determined as 311 pmol using the BCA protein assay, which is 80% of the initial protein concentration. The concentration of 3 in the sample was below the limit of quantitation (<0.45 pmol). The presence of high amounts of salts in the elution buffer has ruled out the possibility to reduce the sample volume in this case. Nevertheless, the amounts of bound compounds show excellent agreement with the K i values. The relative standard deviation for compounds 4 and 5 was 21% and 8% (4 different runs), respectively. The total LC-MS runtime was 10 min in both cases. The limits of detection and the quantitation of tight binding inhibitors are summarized in Table 1 .
DISCUSSION
The quantitation data summarized in Table 1 reveal that there is excellent agreement between the inhibitory constants (K i ) and the amount of the enzyme-bound inhibitors (i.e., 18 ± 3 pmol and 347 ± 27 pmol for 4 and 5, respectively). Apparently, these potent inhibitors remain bound to CPA during the incubation and gel filtration. These results suggest that the present method is potentially useful for the detection and quantitation of protein-bound compounds in a complex matrix. It is worthy of mentioning that the method does not require denaturation of the protein to disrupt the protein-compound complexes. The disruption of the complex was affected simply by treatment with acid.
In general, the mass spectral detection and quantitation of protein-bound compounds are problematic due to the presence of a large amount of salts in samples, which interfere with the detection of analytes. In the case of CPA, the enzyme needs high salt concentration for stability and optimal activity. 19 In this regard, Constantopoulos et al. 20 have reported that the analyte response will decrease with increasing electrolyte concentration. In the present study, the use of an automatic switching valve during LC-MS analyses proved effective to minimize the ion suppression to a considerable extent, thus enabling the quantitation of the CPAbound inhibitors present above the detection limit.
CONCLUSIONS
We have developed a mass spectrometry-based screening method for CPA inhibitors having K i values below 0.6 µM, and we obtained a good correlation between the amount of enzyme-bound inhibitors and the K i values. The described methodology allows the detection and quantitation of protein-bound compounds in the samples containing salts in high concentrations. In addition, it does not require denaturation of the protein and desalting prior to LC-MS analyses, thereby reducing steps for library screening.
This method has a higher throughput than previously described methods 21 because it involves the analysis of a high-molecular weight fraction after SEC, thereby reducing time and labor needed for a complete elution (repetitive cycles) of low-molecular weight compounds from gel filtration columns, including sample drying. Furthermore, it not only provides the binding rank order of the tight binding compounds but also gives directly the amount of compounds bound to the target protein. Finally, this is a promising approach and might be used for the screening of large compound libraries and the quantitation of bound ligands for other enzyme inhibitor complexes.
